M.A. Viviani

912 total citations
14 papers, 593 citations indexed

About

M.A. Viviani is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, M.A. Viviani has authored 14 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Epidemiology and 3 papers in Small Animals. Recurrent topics in M.A. Viviani's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (7 papers) and Infectious Diseases and Mycology (2 papers). M.A. Viviani is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (7 papers) and Infectious Diseases and Mycology (2 papers). M.A. Viviani collaborates with scholars based in Italy, Belgium and United Kingdom. M.A. Viviani's co-authors include H. G. Prentice, Paolo Ricci, F. Meunier, J Tollemar, Jean Klášterský, S Tura, P Fenaux, Olle Ringdén, Anna Maria Tortorano and Mahmoud A. Ghannoum and has published in prestigious journals such as Intensive Care Medicine, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

M.A. Viviani

13 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Viviani Italy 9 440 370 71 65 62 14 593
C A Lyman United States 17 578 1.3× 473 1.3× 99 1.4× 101 1.6× 68 1.1× 23 775
Peter Francis United States 7 508 1.2× 377 1.0× 80 1.1× 39 0.6× 102 1.6× 9 613
G. St‐Germain Canada 15 589 1.3× 533 1.4× 92 1.3× 88 1.4× 46 0.7× 22 740
Cristina Gil‐Lamaignere Greece 17 661 1.5× 555 1.5× 157 2.2× 67 1.0× 38 0.6× 23 791
Jelena Catania United States 6 620 1.4× 541 1.5× 47 0.7× 58 0.9× 41 0.7× 11 706
Luis Thompson Chile 11 477 1.1× 406 1.1× 24 0.3× 36 0.6× 50 0.8× 29 595
Myrna Candelario United States 6 535 1.2× 416 1.1× 76 1.1× 25 0.4× 40 0.6× 7 581
Daniel Friedman United States 8 282 0.6× 260 0.7× 35 0.5× 55 0.8× 38 0.6× 20 455
Süleyha Hilmioğlu Polat Türkiye 17 481 1.1× 518 1.4× 59 0.8× 56 0.9× 30 0.5× 48 820
Marife Martinez United States 17 403 0.9× 334 0.9× 42 0.6× 131 2.0× 17 0.3× 34 597

Countries citing papers authored by M.A. Viviani

Since Specialization
Citations

This map shows the geographic impact of M.A. Viviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Viviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Viviani more than expected).

Fields of papers citing papers by M.A. Viviani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Viviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Viviani. The network helps show where M.A. Viviani may publish in the future.

Co-authorship network of co-authors of M.A. Viviani

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Viviani. A scholar is included among the top collaborators of M.A. Viviani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Viviani. M.A. Viviani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ashbee, H. R., M.A. Viviani, B. Dupont, et al.. (2008). Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Medical Mycology. 46(1). 57–65. 88 indexed citations
2.
Gallelli, Beniamina, M.A. Viviani, Manuela Nebuloni, et al.. (2006). Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of the literature. Journal of Nephrology. 19(5). 668–672. 24 indexed citations
3.
Bonavina, Luigi, et al.. (2003). Candida colonization in patients with esophageal disease: a prospective clinical study. Diseases of the Esophagus. 16(2). 70–72. 18 indexed citations
4.
Tortorano, Anna Maria, Éric Dannaoui, Joseph Meletiadis, et al.. (2002). Effect of Medium Composition on Static and Cidal Activity of Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Terbinafine AgainstAspergillus fumigatus:A Multicenter Study. Journal of Chemotherapy. 14(3). 246–252. 8 indexed citations
5.
Tortorano, Anna Maria, Éric Dannaoui, Massimo Cogliati, et al.. (2000). Evaluation of different in vitro procedures for testing amphotericin B and itraconazole susceptibility of Aspergillus fumigatus.. Journal de Mycologie Médicale. 10(3). 123–127. 7 indexed citations
6.
Berlot, Giorgio, M.A. Viviani, & Rossana Bussani. (2000). An uncommon cause of lower limb weakness. Intensive Care Medicine. 26(1). 128–130. 4 indexed citations
7.
Walsh, Thomas J., M.A. Viviani, Eduardo Arathoon, et al.. (2000). New targets and delivery systems for antifungal therapy. Medical Mycology. 38(s1). 335–347. 118 indexed citations
8.
Viviani, M.A., et al.. (1999). Chronic Pulmonary Histoplasmosis in a Patient with a Recent History of Tuberculosis and Persistent Round Lung Lesions. European Journal of Clinical Microbiology & Infectious Diseases. 18(3). 229–231. 8 indexed citations
9.
Viviani, M.A.. (1995). Flucytosine—what is its future?. Journal of Antimicrobial Chemotherapy. 35(2). 241–244. 20 indexed citations
10.
Viviani, M.A.. (1992). Opportunistic Fungal Infections in Patients with Acquired Immune Deficiency Syndrome. Chemotherapy. 38(1). 35–42. 14 indexed citations
11.
12.
Cofrancesco, E., Carla Boschetti, M.A. Viviani, et al.. (1992). Efficacy of liposomal amphotericin B (AmBisome) in the eradication of Fusarium infection in a leukaemic patient.. PubMed. 77(3). 280–3. 23 indexed citations
13.
Ringdén, Olle, F. Meunier, J Tollemar, et al.. (1991). Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy. 28(suppl B). 73–82. 222 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C A Lyman Breakdown of academic impact, for papers by Peter Francis Breakdown of academic impact, for papers by G. St‐Germain Breakdown of academic impact, for papers by Cristina Gil‐Lamaignere Breakdown of academic impact, for papers by Jelena Catania Breakdown of academic impact, for papers by Luis Thompson Breakdown of academic impact, for papers by Myrna Candelario Breakdown of academic impact, for papers by Daniel Friedman Breakdown of academic impact, for papers by Süleyha Hilmioğlu Polat Breakdown of academic impact, for papers by Marife Martinez
Rankless by CCL
2026